Dan Li
Clinical Medicine College of Yangzhou University, Yangzhou, 225000, Jiangsu, China
Feng Jin
Clinical Medicine College of Yangzhou University, Yangzhou, 225000, Jiangsu, China
Tengyang Ni
Clinical Medicine College of Yangzhou University, Yangzhou, 225000, Jiangsu, China
Li Tao
Clinical Medicine College of Yangzhou University, Yangzhou, 225000, Jiangsu, China
LiveDNA: 86.12988
Haibo Wang
Clinical Medicine College of Yangzhou University, Yangzhou, 225000, Jiangsu, China
Qingtong Shi
Department of Thoraic Surgery, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, 225000, Jiangsu, China
Yayun Qian
Clinical Medicine College of Yangzhou University, Yangzhou, 225000, Jiangsu, China
Yanqing Liu
The State Administration of Traditional Chinese Medicine, Key Laboratory of Toxic Pathogens-Based Therapeutic Approaches of Gastric
Cancer, Yangzhou University, Yangzhou, 225000, Jiangsu, China
LiveDNA: 86.23350
Yali Diao
Department of Thoraic Surgery, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, 225000, Jiangsu, China
LiveDNA: 86.24132
PDF Fulltext XML References Citation
How to cite this article
Dan Li, Feng Jin, Tengyang Ni, Li Tao, Haibo Wang, Qingtong Shi, Yayun Qian, Yanqing Liu and Yali Diao, 2019. Mechanism of Jinlong Capsule (JLC) in Human Esophageal Squamous Cell Carcinoma (ESCC) via the MAPK Signal Pathway. International Journal of Pharmacology, 15: 74-83.
DOI: 10.3923/ijp.2019.74.83
URL: https://scialert.net/abstract/?doi=ijp.2019.74.83
DOI: 10.3923/ijp.2019.74.83
URL: https://scialert.net/abstract/?doi=ijp.2019.74.83